查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
犬類關節炎治療市場規模、佔有率和成長分析（按關節炎類型、給藥途徑、治療方法、最終用戶、分銷管道和地區分類）—產業預測（2026-2033 年）
市場調查報告書
商品編碼
1897183

犬類關節炎治療市場規模、佔有率和成長分析（按關節炎類型、給藥途徑、治療方法、最終用戶、分銷管道和地區分類）—產業預測（2026-2033 年）

Canine Arthritis Treatment Market Size, Share, and Growth Analysis, By Arthritis Type, By Route of Administration, By Treatment, By End-Users, By Distribution Channel, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球犬類關節炎治療市場規模預計在 2024 年達到 28.3 億美元，從 2025 年的 29.7 億美元成長到 2033 年的 43.1 億美元，在預測期（2026-2033 年）內複合年成長率為 4.8%。

全球犬類關節炎治療市場正經歷顯著成長，主要受犬類骨關節炎盛行率上升（與老齡化、肥胖以及某些犬種等因素相關）的推動。飼主越來越重視寵物的行動和疼痛問題，尤其是在獸醫服務和早期診斷水平較高的已開發地區，他們更重視帶寵物就醫。對包括單株抗體、非類固醇消炎劑(NSAIDs) 和再生醫學在內的長期治療方案的需求，正在塑造著市場的主要趨勢。此外，遠端醫療服務和線上獸醫診所的擴張也加速了市場滲透。寵物醫療保健和預防保健成本的不斷上漲，促使動物用藥品商持續加強研發投入和產品創新，進一步支撐了市場的強勁前景。

全球犬類關節炎治療市場促進因素

全球犬類關節炎治療市場主要受營養學和獸醫學進步的推動，這些進步使犬隻能夠活得更長久、更健康。隨著老年犬數量的增加，關節炎等老齡化相關疾病的盛行率也隨之上升，推動了對健康維護支援和慢性病照護方案的需求。這種人口結構的變化是市場發展的關鍵促進因素，促使人們持續投資於旨在促進長期關節健康的有效治療方法和藥物。由此產生的對老年犬的日益關注，為該領域的創新和發展創造了良好的環境。

全球犬類關節炎治療市場限制因素

生技藥品和再生療法的高昂費用限制了寵物飼主，尤其是在中低收入地區，獲得這些療法的機會。遍遠地區獸醫專家的短缺進一步加劇了這項挑戰，阻礙了這些先進療法的及時診斷和治療。因此，這些障礙不僅限制了再生療法的普及，也阻礙了新興市場寵物醫療保健體系的發展。由此，許多寵物飼主在尋求犬類關節炎的有效治療方法時面臨著許多困難，這影響了全球犬類關節炎治療市場的整體成長潛力。

全球犬類關節炎治療市場趨勢

全球犬類關節炎治療市場正顯著轉向生技藥品和再生醫學，尤其是單株抗體和幹細胞療法。這一趨勢強調開發針對特定患者、永續的解決方案，以提供長期疼痛緩解並最大限度地減少副作用。這些創新不僅滿足了對標靶有效治療方法日益成長的需求，也體現了獸醫學領域更廣泛的策略，即加強慢性病護理。隨著市場的發展，治療方法的進步正在加速，以滿足患有關節炎的動物的需求，這反映了人們致力於提高其生活品質的決心。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 一手和二手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 技術分析
  • 用例

全球犬類關節炎治療市場規模（依關節炎類型分類）及複合年成長率（2026-2033 年）

  • 骨關節炎
  • 骨軟骨病
  • 類風濕性關節炎
  • 創傷性關節炎

全球犬類關節炎治療市場規模（依給藥途徑及複合年成長率分類）（2026-2033 年）

  • 口服
  • 腸外
  • 其他

全球犬類關節炎治療市場規模（依治療方法分類）及複合年成長率（2026-2033 年）

  • 非類固醇消炎劑（NSAIDs）
  • 鴉片類藥物
  • 幹細胞療法
  • 異體幹細胞
  • 自體幹細胞

全球犬類關節炎治療市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

  • 醫院
  • 專科診所
  • 其他

全球犬類關節炎治療市場規模（依通路分類）及複合年成長率（2026-2033 年）

  • 獸醫醫院和診所
  • 零售藥房
  • 網路藥房
  • 其他

全球犬類關節炎治療市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • GCC
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

    主要企業簡介

    • Boehringer Ingelheim
    • Zoetis
    • Elanco
    • Decora Pharmaceuticals
    • Merck Animal Health
    • American Regent, Inc.
    • Bayer AG
    • Nutramax Laboratories Veterinary Sciences, Inc.
    • VetStem, Inc.
    • Virbac

結論與建議

簡介目錄
Product Code: SQMIG35I2385

Global Canine Arthritis Treatment Market size was valued at USD 2.83 Billion in 2024 and is poised to grow from USD 2.97 Billion in 2025 to USD 4.31 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global canine arthritis treatment market is witnessing significant growth, driven by the rising prevalence of osteoarthritis in dogs, often linked to factors like age, obesity, and specific breeds. Pet owners are increasingly prioritizing veterinary care for mobility and pain-related concerns, particularly in developed regions where access to veterinary services and early diagnosis has improved. The demand for long-term therapeutics, including monoclonal antibodies, NSAIDs, and regenerative medicine, is shaping key market trends. Additionally, the expansion of telehealth services and online veterinary pharmacies is accelerating market penetration. Continued investments in research, development, and product innovation by veterinary pharmaceutical companies further bolster a strong market outlook, underpinned by growing expenditures on pet healthcare and preventive treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Arthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Canine Arthritis Treatment Market Segments Analysis

Global Canine Arthritis Treatment Market is segmented by Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel and region. Based on Arthritis Type, the market is segmented into Osteoarthritis, Osteochondrosis, Rheumatoid arthritis and Traumatic arthritis. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on Treatment, the market is segmented into Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells and Autologous Stem Cells. Based on End-Users, the market is segmented into Hospitals, Speciality Clinics and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is significantly driven by advancements in nutrition and veterinary care that enable dogs to enjoy longer, healthier lives. As the population of aging dogs increases, so does the prevalence of age-related conditions like arthritis, leading to a heightened demand for wellness support and chronic care options. This demographic shift serves as a key factor in driving the market, prompting continuous investments in effective treatments and medications aimed at promoting long-term joint health. Consequently, the focus on older canines is fostering a robust environment for innovation and development within the sector.

Restraints in the Global Canine Arthritis Treatment Market

The elevated expenses associated with biologics and regenerative treatments restrict access for pet owners, particularly in low- and middle-income areas. This challenge is exacerbated by the scarcity of veterinary specialists in rural regions, which hinders timely diagnosis and management of these advanced therapies. Consequently, such obstacles not only limit the adoption of regenerative treatments but also stifle the advancement of pet healthcare systems in emerging markets. As a result, many pet owners face significant barriers in seeking effective solutions for canine arthritis, thereby impacting the overall growth potential of the global canine arthritis treatment market.

Market Trends of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is witnessing a notable shift towards biologic and regenerative therapies, particularly monoclonal antibodies and stem cell treatments. This trend emphasizes the development of patient-specific and sustainable solutions that offer prolonged pain relief while minimizing adverse effects. Such innovations not only align with the growing demand for targeted and effective therapies but also highlight a broader strategy within veterinary medicine focused on enhancing chronic care. As the market evolves, there is a clear inclination towards accelerating therapeutic advancements that cater to the needs of animals suffering from arthritis, reflecting a commitment to improving their quality of life.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies

Global Canine Arthritis Treatment Market Size by Arthritis Type & CAGR (2026-2033)

  • Market Overview
  • Osteoarthritis
  • Osteochondrosis
  • Rheumatoid arthritis
  • Traumatic arthritis

Global Canine Arthritis Treatment Market Size by Route of Administration & CAGR (2026-2033)

  • Market Overview
  • Oral
  • Parenteral
  • Others

Global Canine Arthritis Treatment Market Size by Treatment & CAGR (2026-2033)

  • Market Overview
  • Non-steroidal anti-inflammatory Medications (NSAIDs)
  • Opioids
  • Stem Cell Therapy
  • Allogeneic Stem Cells
  • Autologous Stem Cells

Global Canine Arthritis Treatment Market Size by End-Users & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Speciality Clinics
  • Others

Global Canine Arthritis Treatment Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Global Canine Arthritis Treatment Market Size & CAGR (2026-2033)

  • North America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
    • US
    • Canada
  • Europe (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Boehringer Ingelheim
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Decora Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck Animal Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • American Regent, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutramax Laboratories Veterinary Sciences, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VetStem, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations